KR Choksey has come out with its first quarter (April-June) earnings estimates for the Pharma sector. The brokerage house expects Cipla to report net profit at 199.6 crore down 46.52% year-on-year (427.75% quarter-on-quarter).
Net Sales are expected to decrease by 4.43 percent Q-o-Q (down 4.78 percent Y-o-Y) to Rs 3332.5 crore, according to KR Choksey.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 0.59 percent Q-o-Q (down 17.64 percent Y-o-Y) to Rs 503.2 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.